August 24, 2016
Corium Announces Streamlined Bioequivalence Development Path for Transdermal CorplexTM Memantine
Second Alzheimer’s Candidate to Follow Shortened Clinical Timeline…
Corium Announces Streamlined Bioequivalence Development Path for Transdermal CorplexTM Memantine
Second Alzheimer’s Candidate to Follow Shortened Clinical Timeline…